Loading clinical trials...

COMPLETEDNANCT02015598

Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnoea Syndrome

Obstructive sleep apnoea syndrome (OSAS) is characterised by repeated episodes of upper airway occlusion during sleep.It can cause cycles of hypoxia reoxygenation. And it was postulated that intermitt...

Lead sponsor: Guangzhou Institute of Respiratory Disease•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Not Yet Recruiting

Entropy-based Physiological Signal Analysis in Patients With Obstructive Sleep Apnoea

NCT07406620 · Obstructive Sleep Apnoea (OSA)

SUSPENDEDNA

Clinical Trial of a Rehabilitation Device Based on Electrostimulation for Obstructive Sleep Apnoea

NCT04607343 · Obstructive Sleep Apnoea

COMPLETEDNA

EndoBarrier in Obstructive Sleep Apnoea Study

NCT06376305 · Type 2 Diabetes, Obstructive Sleep Apnoea, and more

WITHDRAWN

Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)

NCT01458613 · Lysosomal Storage Disease, Lung Diseases, and more

COMPLETED

Effect of Bariatric Surgery on Obstructive Sleep Apnea in a Danish Cohort

NCT02012868 · Obstructive Sleep Apnoea (OSA)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 7, 2015Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment40

Start dateDec 2013

Last updatedJan 7, 2015

Condition

Obstructive Sleep Apnoea

Locations shown

Guangzhou institute of respiratory disease

Guangzhou, Guangdong

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 7, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions